DE69232162T2 - Hapten-Analoge zur Verwendung in Immunoassays - Google Patents

Hapten-Analoge zur Verwendung in Immunoassays

Info

Publication number
DE69232162T2
DE69232162T2 DE69232162T DE69232162T DE69232162T2 DE 69232162 T2 DE69232162 T2 DE 69232162T2 DE 69232162 T DE69232162 T DE 69232162T DE 69232162 T DE69232162 T DE 69232162T DE 69232162 T2 DE69232162 T2 DE 69232162T2
Authority
DE
Germany
Prior art keywords
nucleus
immunoassays
hapten
ester group
drug hapten
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232162T
Other languages
English (en)
Other versions
DE69232162D1 (de
Inventor
Susan Jean Danielson
Marsha D Oenick
Ignazio Ponticello
David Alan Hilborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Johnson and Johnson Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Clinical Diagnostics Inc filed Critical Johnson and Johnson Clinical Diagnostics Inc
Application granted granted Critical
Publication of DE69232162D1 publication Critical patent/DE69232162D1/de
Publication of DE69232162T2 publication Critical patent/DE69232162T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
DE69232162T 1991-06-07 1992-06-02 Hapten-Analoge zur Verwendung in Immunoassays Expired - Lifetime DE69232162T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71232991A 1991-06-07 1991-06-07
US07/851,435 US5284948A (en) 1991-06-07 1992-03-16 Drug hapten analogues for immunoassays

Publications (2)

Publication Number Publication Date
DE69232162D1 DE69232162D1 (de) 2001-12-06
DE69232162T2 true DE69232162T2 (de) 2002-07-11

Family

ID=27108809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232162T Expired - Lifetime DE69232162T2 (de) 1991-06-07 1992-06-02 Hapten-Analoge zur Verwendung in Immunoassays

Country Status (5)

Country Link
US (1) US5284948A (de)
EP (1) EP0517325B1 (de)
JP (1) JP3190728B2 (de)
AT (1) ATE208042T1 (de)
DE (1) DE69232162T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents
US7154021B2 (en) * 2000-01-07 2006-12-26 Monsanto Technology Llc Nucleic acid molecules and other molecules associated with soybean cyst nematode resistance
US6991911B2 (en) 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US7022492B2 (en) 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US7115383B2 (en) 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
US7037669B2 (en) 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US8133743B2 (en) * 2007-10-19 2012-03-13 Roche Diagnostics Operations, Inc. Phenobarbital derivatives useful in immunoassay
CN103364556B (zh) * 2012-04-05 2016-02-24 北京勤邦生物技术有限公司 一种检测呋喃妥因代谢物的试剂盒及方法
EP3556759B1 (de) * 2012-08-21 2023-11-29 Janssen Pharmaceutica NV Haptene von paliperidon
KR101515020B1 (ko) 2013-11-13 2015-04-24 에스케이텔레콤 주식회사 햅텐 및 이에 결합하는 항체를 레퍼런스 항체로 이용하는 면역학적 측정 방법 및 상기 레퍼런스 항체를 이용한 면역학적 측정장치
CN110054620B (zh) * 2019-04-19 2021-01-26 北京九强生物技术股份有限公司 一种苯巴比妥衍生物及其在免疫检测中的用途
CN111875587B (zh) * 2020-07-23 2021-07-13 湖南苏阳医疗科技有限公司 5-氟胞嘧啶衍生物、其制备方法及其在5-氟胞嘧啶免疫检测试剂中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065354A (en) * 1974-10-10 1977-12-27 Syva Company Lysozyme conjugates for enzyme immunoassays
US4092479A (en) * 1976-04-05 1978-05-30 Baxter Travenol Laboratories, Inc. Labeled 5,5-diphenylhydantoin derivatives for radioimmunoassay
US4182856A (en) * 1978-04-25 1980-01-08 Miles Laboratories, Inc. Reagents for use in binding assays to determine diphenylhydantoin
US4244939A (en) * 1978-06-12 1981-01-13 Baxter Travenol Laboratories, Inc. Barbituric acid tracers and their preparation
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
NZ199629A (en) * 1981-02-17 1984-11-09 Abbott Lab Fluorescent polarisation immunoassay and certain substituted carboxy fluoresceins
US4670381A (en) * 1985-07-19 1987-06-02 Eastman Kodak Company Heterogeneous immunoassay utilizing horizontal separation in an analytical element
US4752568A (en) * 1986-01-13 1988-06-21 Eastman Kodak Company Labeled hydantoin conjugate and its use in analytical element and immunoassays
ATE154135T1 (de) * 1989-03-10 1997-06-15 Hoffmann La Roche Reagenzien zum nachweis von drogen

Also Published As

Publication number Publication date
JP3190728B2 (ja) 2001-07-23
EP0517325A3 (en) 1993-04-07
EP0517325A2 (de) 1992-12-09
ATE208042T1 (de) 2001-11-15
DE69232162D1 (de) 2001-12-06
US5284948A (en) 1994-02-08
EP0517325B1 (de) 2001-10-31
JPH0627107A (ja) 1994-02-04

Similar Documents

Publication Publication Date Title
DK0672057T3 (da) Analoger af PTH
ATE106401T1 (de) Benzodiazepin-analoge.
ATA53492A (de) Verwendung von ciclosporin zur pulmonalen verabreichung
ATE214698T1 (de) Neue carbamazepin hapten analoge
NO903454L (no) Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav.
DK295288A (da) (1h-azol-1-ylmethyl)substituerede benzotriazolderivater
DE69232162T2 (de) Hapten-Analoge zur Verwendung in Immunoassays
FI851261A0 (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
DE69232002D1 (de) Immunoassays unter Verwendung von markierten Hapten-Analogen
FI882495A0 (fi) Anordning foer avspolning av tillsammans med ett spolband i fjaellform pao en spolkaerna uppspolade trycksaker.
ITPD920146A0 (it) Nuovi derivati dell'acido neuraminico
FI881413A0 (fi) Foerfarande foer framstaellning av 3'-azido-3'-deoxitymidin.
MC1981A1 (fr) Derives d'acides catechol carboxyliques
IT1222986B (it) Derivati dell'efedrina esterificata aventi attivita' antiulcera prolungata nel tempo
DK448288A (da) Ethanolaminderivater
DK258988A (da) Individuelle isomere af endo-bicyclo(2.21)heptyladenosin
DE69232001T2 (de) Markierte Hapten-Analoge zur Verwendung in Immunoassays
DK273990D0 (da) Paavisning af modtagelighed for sygdom
IT8821135A0 (it) Derivato dell'acido ursodesossicolico.
KR890021037U (ko) 전망용 엘리베이터의 광고장치
FR2604841B1 (fr) Dispositif de transformation d'un signal par stabilisation et rehaussement de la dynamique dudit signal
DE3787471T2 (de) 4"-Desoxy-3"-demethoxy-3"-methylen-desmycosin-Derivate.
BR8703239A (pt) Gerador eletronico estabilizado
IT8921431A0 (it) Circuito di compensazione per il tempo di attesa di un segnale di luminosita' in una tv multimodale.
IT1222553B (it) Derivati dell' s-carbossimetilcisteina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

R071 Expiry of right

Ref document number: 517325

Country of ref document: EP